14 May 2024
31st Russian Pharmaceutical Forum named after N.A. Semashko was launched in St. Petersburg today, May 14. Heads of pharmaceutical companies, government agencies and specialized associations are here to discuss the most pressing issues of the industry, give their assessments and forecasts, and propose ways to tackle challenges such as drug price regulation, elimination of shortages, development of API production in Russia, necessary government support measures, entering markets of friendly countries, etc.
Forum participants note the high activity and engagement of representatives of foreign and domestic pharmaceutical companies in discussing current issues of price regulation, innovative activity of Russian manufacturers and search for export markets.
NovaMedica is represented at the forum by its CEO and member of the Board of Directors Elena LITVINOVA and the Head of the company’s Business Unit Oksana KRASNYKH.
NovaMedica’s experts will participate in the discussion on optimizing timelines and budgets for creation of new drugs as part of the session “Clinical trials. Current situation in the Russian market. New challenges, pressing issues and solutions”. NovaMedica will also share its experience of interacting with the medical community and implementing the very important programs to improve diagnosis of CNS diseases at the session “Strategic marketing – increasing the efficiency of marketing campaigns in the changing landscape of the pharmaceutical industry”.
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025